Purpose: This study was aimed to examine the efficacy of modified constraint-induced movement therapy (mCIMT), which was applied to lower extremity, on strength and quality of life (QoL) in patients with stroke.
INTRODUCTION
Stroke is one of the significant factors for disability and mortality in the developed world (1) . Patients with stroke can live longer, despite the high rates of disability and morbidity associated with stroke (2) . Disability and morbidity elicit an attenuation in quality of life (QoL) in patients with stroke (3) . The QoL has a multidimensional structure that includes physical, psychologic, functional, and social health-related domains. Carod et al. showed that mobility and muscle strength were the most highly correlated domains with health-related QoL (4) . Therefore, rehabilitation programs, which are aimed to improve QoL, should be targeted primarily at the mobility and strength of paretic lower extremity. There are many different rehabilitation approaches to improve lower extremity function (5) . Regardless of which the rehabilitation approach used, first it is necessary to break the "learned misuse" phenomenon that has developed in the lower extremity because one of the main problems following stroke is the misuse of paretic lower extremity during mobility (6) . Some authors have reported that patients with stroke are in tendency prefer to use the nonparetic lower extremity during functional activities and even during exercise sessions depending on the inefficacy in weightbearing tasks of paretic extremity (7) . Despite this inclination to use the nonparetic extremity, the practicability and efficiency of the rehabilitation approaches which promote the use of paretic lower extremity should be improved (8) .
In recent years, constraint-induced movement therapy (CIMT) or modified CIMT, which was first used for upper extremity rehabilitation, has begun to be used for lower extremity as well (9) (10) (11) (12) . Even though there are some difficulties for lower extremity rehabilitation with mCIMT in clinical settings, many researchers have tried it nonetheless and have shown that CIMT or mCIMT significantly improved motor functions (9, 10, (12) (13) (14) .
However, to our knowledge, the effects of mCIMT on the lower extremities on QoL and muscle strength have not yet been investigated. Therefore, the present study aimed to evaluate the efficacy of mCIMT on QoL and muscle strength in stroke survivors. In addition, we also investigated the association between the total developments in muscle strength and QoL and particular change according to the treatment period.
METHODS

Study Design and Participants
This study was designed as a prospective, singleblind, randomized controlled study. The sample size was determined by G*Power 3.0.10 (G*Power 3.1 software, F. Faul, E. Erdfelder, A.G. Lang and A. Buchner, University of Kiel, Germany; http://www. gpower.hhu.de). The confidence level was set at 5% with power 80%. An average difference between groups for the SIS score was postulated 9.09 according to a previous study (15) . The sample size calculated as 11, but at least 15 participants were included in each group to prevent dropouts. Before they were randomized into two groups, the participants were stratified based on age (≤60 or >60 years), gender, hemiplegic side, type of stroke, and length of time post-stroke to obtain a balanced distribution of the participants according to essential parameters which have known prognostic effects by a physiotherapist (16) . The participants were identified into blocks, and simple randomization is performed using computergenerated random numbers.
Inclusion criteria were as follows: clinical diagnosis of a single, unilateral stroke; being over the age of 18 years; the time since the stroke was between 3 and 12 months; the exhibition of mild to moderate disability according to lower extremity recovery stages (Brunnstrom recovery stages III-V); no attendance in any rehabilitation programme; and permitted to participate in an intensive rehabilitation program. Patients were excluded if they had a recurring stroke; medical comorbidities; cognitive impairment (less than 24 points on the Mini-Mental Status Examination); additional neurological or orthopedic problems. Patients were also excluded from the study if they missed ≥3 consecutive treatment sessions. It was especially noted that the medical condition of the participants was stable and had not previously received physiotherapy, so the participants were called from the patient list, that waiting to receive physiotherapy for the first time. Signed informed consent was obtained from all participants, as approved by the Hacettepe University Ethics Committee (GO 14/22-15).
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Outcome Measures
All participants were evaluated by a physiotherapist who was blinded to their grouping, a total of three times, at baseline, post 4 weeks, and post 6 weeks.
The Motricity Index is a useful, valid and reliable assessment tool for muscle strength that can predict mobility outcomes poststroke (17) . Hip flexion, knee extension, and ankle dorsiflexion were graded based on weighted scores between 0 and 33, as Motricity Scores (18) . During the test, the patient applied force against resistance. The score was recorded according to the quality of muscle contraction. Finally, all three scores were summed with 1 more point added. Then, the scores for the lower extremities, which changed from 0 (paresis) to 100 (normal), were calculated.
Quality of life was determined using the Turkish version of the Stroke Specific Quality of Life (SSQoL) scale (19) . This tool is a patient-oriented questionnaire including of 12 domains, such as self-care, vision, language, mobility, work, upper extremity, thinking, personality, mood, family, social roles, and energy. Each domain scored between 1 and 5 (20) . A total score and the score of each subdomain were calculated separately.
The Turkish translated Stroke Impact Scale (SIS), version 3.0, was used to determine the impact of stroke on patients (21) . The SIS contains eight domains, but only the lower extremity strength (2 items), mobility (9 items) domains were used in the present study. Each item is scored on a 5-point scale, and total scores of each domain could change between 0 and 100. In addition, one question investigates the amount of the perceived recovery after stroke using a Visual Analogue Scale, on 100 scores (22) .
Intervention
The treatment program was conducted in two phases. The first phase was baseline treatment and the second phase was the experimental treatment. The neurodevelopmental therapy (NDT), was also used in the control and study groups during the baseline treatment period (BP), three sessions per week, 60 minutes per session, for four weeks. Each session was executed by a physiotherapist, who had eight years of work experience in the neurologic rehabilitation field. The NDT requires continuous observation, evaluation, progression, and modification of the program dealing with participants' progression (23) . Therefore, the physiotherapist followed the progression to choose appropriate exercises for the patient's abilities and needs. Exercises in the NDT program consisted of weight shifting in different position, facilitation of regular movement pattern (including walking), and balance activities that are based on the motorlearning principle.
During the experimental treatment period (EP), for two weeks, while the NDT was continued to use in the control group, mCIMT was conducted for the paretic lower extremity in the study group. The EP included five sessions per week, with each session lasting 120 minutes for both groups (13) . The CIMT contained three main elements: the intensive practice of the functional activities, restricted use of the nonparetic extremity, and transferring the gains from the training session to the patient's real environment with "transfer package" (23) . The intensive practice was applied with the selection of appropriate functional activities following the "shaping" principles by the feedback, coaching, modeling, and encouragement of the physiotherapist. The functional activities are walking (forward, backward, sidewards), weight-bearing activities to different directions, climbing up and down stairs and ramp, balance activities, stepping over obstacles, working with a bicycle ergometer, and gait training on the treadmill, over 20 minutes, repetitively. After each 20-minute activity period, a rest period of 5 minutes was given. A combination of two different methods fulfilled the constraint of nonparetic lower extremity; immobilization of the knee of the nonparetic extremity with a whole-leg orthosis at the fullest extension position and use of a shoe insert with a 1 cm lift and 5° lateral wedge on the nonparetic lower extremity ( Figure 1 ) (9, 11) . Training on the use of the orthosis and shoe insert was provided for patients and their relatives. The restriction was used during treatment sessions and 90% of the participants' waking hours. The functional activities used during therapy session were set as a home program, and participants were strongly encouraged to use their paretic extremity (13) .
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Statistical Analysis
The data were analyzed with SPSS 20.0 (IBM Corp, Chicago, IL, USA). The Kolmogorov-Smirnov test was used to determine the distribution. Variables were presented as mean±standard deviation. The comparisons of within-group were performed using repeated measures ANOVA, and post hoc tested via the paired sample t-test. The comparisons of the changes after treatment periods between groups were performed using Student t-test. The changes in outcome measures after the BP were evaluated with the difference between the baseline scores and post-baseline treatment scores. The changes in outcome measures during the EP were evaluated with the difference between the post-baseline treatment scores and the post-experimental treatment scores. The changes in outcome measures over the total treatment period (TTP) were evaluated with the difference between the baseline scores and post-experimental treatment scores. In addition, the changes in outcome measures were also evaluated based on minimal detectable change (MDC) values, which was determined by previous studies of Lin et al. (24, 25) . According to these studies, the total MDC value of strength and mobility domain of SIS was 39.1, and the MDC values in the mobility, self-care, and upper extremity function subdomains of SS-QoL were 5.9, 4.0, and 5.3, respectively (25) . The proportions of patients with a change score greater than these MDC values were calculated. The correlation coefficient was calculated using Pearson's test to determine the developments in strength and QoL that is associated with the changes in which treatment period. The significance level was set at p<0.05.
RESULTS
The 30 participants were 16 females and 14 males, with a mean age of 56.40±13.45 years and the mean time post-stroke of 6.70±2.94 months. Figure 2 demonstrates the flowchart of the study. The clinical characteristics of the participants are summarized in Table 1 . Both groups were similar regarding physical characteristics at baseline (p>0.05).
The Motricity Index score increased for BP, EP, and TTP in both groups (p<0.01, Table 2 ). The score increased 19.8 and 13.2 points in the study and control group, after the TTP, respectively. A significant difference of changes in lower extremity strength was seen for the TTP in favor of the mCIMT group (p=0.029), but the changes in BP and EP were found similar among groups (p=0.161 and p=0.129, Table 3 ).
The outcomes of the QoL improved in both groups for all treatment periods (p<0.01, Table 2 ).
Comparison of the changes in the SS-QoL total score and subdomain scores among groups are also detailed in Table 3 . Regarding the SS-QoL total score and their subdomains, the study group showed significant improvement after the EP, in total score (p=0.003), mobility (p=0.004), self care (p=0.002), thinking (p=0.026), mood (p=0.012), family (p=0.01), and social roles (p=0.004) when compared with the control group. The thinking (p=0.043), mood (p=0.002), and personality (p=0.040) scores in the mCIMT group also changed meaningfully over the TTP. After the BP only the mood subdomain improved significantly in the mCIMT group (p=0.009). The subdomains of energy, vision, language, work/productivity scores, and upper extremity function were similar among groups (p>0.05). Efficacy
MDC value in both groups for mobility and upper extremity function subdomains. At the EP and TTP, these proportions increased for mobility and selfcare subdomains in both groups, but in the mCIMT group 2-fold more patients obtained these values.
The proportion of patients exceeded the MDC values of upper extremity function was the lowest level for both groups.
As shown in Table 2 , SIS score changed more over TTP in the study group compared with the control group (p=0.017), but the improvement in the BP and EP did not differ between groups (p=0.118 and p=0.051). In the mCIMT group, the SIS subdomain of the amount of perceived recovery improved significantly more than the control group after the TTP (p<0.001) and EP (p<0.001).
The change at the end of the TTP for the SIS score exceeded the MDC value in the 40% proportions of the mCIMT group and 13.3% of the control group. The changes of SIS score in the BP and EP exceeded the MDC value less than 10% of patients for both groups (Figure 3 ).
For the improvements in strength and QoL of both groups, the correlations between total change and change in BP and between total change and change in EP are shown in Figure 4 . Correlations were found to be significantly strong on the following items: strength (correlation coefficient of BP vs. EP, r=0.660 vs r=0.709, respectively), and QoL of EP (r=0.769). The correlation between total score change and BP in QoL was moderate (r=0.505, p<0.010).
DISCUSSION
This study revealed that mCIMT for the paretic lower extremity improves muscle strength and health- related QoL in patients with stroke, particularly the mobility, self-care, thinking, mood, family, and social roles subdomains. mCIMT can be used as a supportive treatment method to improve the QoL and increase the muscle strength, as a result of the development of paretic lower extremity function, following the stroke.
After the stroke, many approaches consisting of exercise are recommended to improve motor function and health-related QoL (5). Modified CIMT is another method that has been used recently to improve functional performance, particularly concerning gait and balance outcomes (10, (12) (13) (14) 26) . We also published a paper, as a primary result of this study, which demonstrated that mCIMT enhanced the motor function (10). However, outcomes of QoL and strength, as well as motor function, are essential in evaluating the success of an approach.
The assessment and development of muscle strength are essential following a stroke, as muscle weakness probable cause to chronic disability. In this study, in which we examined the effect of mCIMT on muscle strength, we showed that strength improvement in the study group was higher than the control group after the TTP.
Moreover, the improvement after the TTP was correlated more highly with the EP, in particularly mCIMT. Our finding is consistent with the previous studies in which reported that task-oriented rehabilitation methods, such as mCIMT, are beneficial for increasing muscle strength (15, 27) . We thought that the strength development after TTP in the study group is explained by the right, intensive practice of the paretic lower extremity in weight-bearing positions due to the restriction of non-paretic extremity. Therefore, the muscles in the paretic lower extremity may have been extensively activated, and inconsequently the strengthening has occurred.
Gokkaya et al. (28) reported that QoL is poorer in
Turkish stroke survivor than in healthy individuals. One of the significant aims of rehabilitation is to improve QoL. The QoL is closely related to ensuring independence in activities of daily living, especially in the successful continuation of mobility. Therefore, the rehabilitation approaches should target to achieve the lower-extremity functions to an optimal level, which are known in the linear relationship with QoL (4, 28, 29 but it did not result in better QoL (30) . In contrast, we showed that mCIMT had positive effects on QoL, particularly total score, mobility, self-care, social roles, family, mood, thinking subdomains of SS-QoL. In addition, sometimes these changes may not be enough to make a clinical decision. At this point, the MDC values may help the clinician to interpret the outcomes. Thus, the physiotherapist could decide whether to proceed or needs to change the treatment. MDC values of the SS-QoL scale was reported just mobility, self-care and upper extremity function subdomains (25) . The present study showed that the highest proportions of the patients in study groups had an actual improvement in mobility and self-care subdomains of SS-QoL. We attributed this finding that mCIMT for lower extremity involved the intensive practice of the paretic extremity and increased weight-bearing on the paretic lower extremity (10) , and following the mobility, transfer activities and participation improved due to treatment. Consequently, these changes have reflected the QoL.
The patient's thoughts dealing with the treatment methods should be considered, which will help to ensure that the treatment is successful. The SIS includes a domain that evaluates perceived recovery by the patient. Participants have reported that mCIMT contributes more to recovery from the stroke after both the EP and TTP when compared with NDT. When QoL is evaluated using the SIS, QoL has been seen to develop further in the mCIMT group by the effect of total treatment. In this study, only the mobility and lower extremity strength domains of the SIS were used. Therefore, the impact of stroke recovered after six weeks due to the development of strength.
Similarly, at the BP and EP, only one patient exceeded the MDC value of the SIS in both groups, and after the TTP, 40% and 13.3% of the patients in the mCIMT group and the control group, respectively, exceeded the MDC value. This finding suggested that enhancement of SIS after TTP was relating to the strength development. The increased QoL is desired due to the strengthening effect of mCIMT. The mCIMT for 2-weeks can be used interchangeably with other treatment modalities which support motor learning such as NDT. This combined approach may facilitate neural plasticity and accelerate recovery. For instance, mCIMT for lower extremity can be performed for 2-weeks following NDT with four weeks to improve QoL in stroke.
This study was a preliminary study which was used to a double restriction method by knee immobilizer and shoe insert, and we did not predict the patient adherence to the restricting method. Since our patients did not attend any rehabilitation programme, four weeks of baseline treatment was conducted to prepare for intensive EP. Consequently, we applied mCIMT for two weeks that is more effective than four and six weeks of treatment for task-oriented training as it has been shown in a previous study (27) . The patient adherence to treatment, and orthosis was observed well. Therefore double restriction method can be confidently used to improve muscle strength and QoL.
Patients in both groups were encouraged to pursue their daily life and home program. However, adherence to the home program and the wear time of the restriction orthosis out of the session was not monitored. We thought that this was one limitation of the present study. Although both groups received the same intensity treatment, the mCIMT group arguably received more "treatment" due to restriction orthosis and transfer package. This point is regarded as a common limitation of all CIMT studies. Another limitation was the lack of proportions of patients who exceeded the MDC value of Motricity Index, SS-QoL total score, and its other subdomains. There was no study relating to these MDC values in the literature. The other limitations of our study include the findings could only be generalized to patients who met the inclusion criteria and the lack of evaluations of the participants' activity levels before treatment. The physical activity level may be a predictive factor. The effect of mCIMT according to the activity levels of the patients can be investigated with further studies. Besides these limitations, this study also had several strengths. The main strengths of this study were being a randomized controlled study, being the first study to show the effects of mCIMT, as applied to the lower extremities on QoL and strength, and last QoL had been considered comprehensively.
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In conclusion, mCIMT for paretic lower extremity resulted in improvements in QoL after the EP and TTP, and in strength after the TTP. Furthermore, the improvements in TTP were correlated strongly with the EP.
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